Approval · Notice of Compliance 2877 · 1998
EMADINE: Notice of Compliance 2877
Issued February 16, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2877
- Date
- February 16, 1998
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiallergic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EMADINE | 02237355 | Cancelled Post Market |
Medicinal ingredients
- EMEDASTINE DIFUMERATE 0.05 PER